Mohammad Sayyah Selected Research

Pentylenetetrazole (Metrazol)

1/2021	Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABAA Receptors.
1/2021	The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
8/2019	Complex network based models of ECoG signals for detection of induced epileptic seizures in rats.
10/2018	A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole.
10/2017	Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice.
1/2017	Toxoplasmosis accelerates acquisition of epilepsy in rats undergoing chemical kindling.
1/2017	In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures.
3/2016	Traumatic brain injury accelerates kindling epileptogenesis in rats.
12/2015	Lipopolysaccharide preconditioning prevents acceleration of kindling epileptogenesis induced by traumatic brain injury.
10/2015	Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Sayyah Research Topics

Disease

28	Seizures (Absence Seizure) 01/2021 - 10/2002
14	Epilepsy (Aura) 01/2021 - 01/2005
5	Neuroinflammatory Diseases 04/2013 - 12/2003
4	Rabies (Hydrophobia) 07/2022 - 01/2018
4	Infections 01/2022 - 01/2017
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 12/2015
4	Inflammation (Inflammations) 07/2020 - 06/2004
3	Toxoplasmosis 01/2021 - 10/2017
3	Alzheimer Disease (Alzheimer's Disease) 04/2019 - 10/2018
2	Cysts 01/2021 - 01/2017
2	Temporal Lobe Epilepsy 01/2020 - 10/2017
2	Infarction (Infarctions) 11/2018 - 01/2018
2	Cognitive Dysfunction 11/2018 - 01/2018
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2017 - 01/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2013 - 10/2012
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Necrosis 01/2021
1	Persistent Infection 01/2021
1	Drug Resistant Epilepsy 09/2019
1	Gliosis 01/2019
1	Wounds and Injuries (Trauma) 10/2018
1	Ischemia 01/2018
1	Memory Disorders (Memory Loss) 09/2017
1	Drug-Related Side Effects and Adverse Reactions 06/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013

Drug/Important Bio-Agent (IBA)

17	Pentylenetetrazole (Metrazol)IBA 01/2021 - 10/2002
12	Anticonvulsants (Antiepileptic Drugs)IBA 09/2019 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
6	LipopolysaccharidesIBA 12/2015 - 12/2003
4	Glycoproteins (Glycoprotein)IBA 07/2022 - 01/2018
4	salicylhydroxamic acid (SHAM)IBA 11/2018 - 03/2016
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2011
3	Docosahexaenoic AcidsIBA 09/2019 - 01/2017
3	Connexin 43 (Connexin43)IBA 01/2017 - 04/2010
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 10/2015
2	Lamotrigine (Lamictal)FDA LinkGeneric 09/2019 - 10/2015
2	Amyloid beta-PeptidesIBA 04/2019 - 10/2018
2	monophosphoryl lipid AIBA 10/2018 - 01/2018
2	Quinine (Quinson)FDA Link 11/2016 - 01/2013
2	Gap Junction delta-2 ProteinIBA 01/2013 - 04/2010
2	Messenger RNA (mRNA)IBA 12/2012 - 04/2010
1	CorticosteroneIBA 01/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	2-aminoethyl diphenylborinateIBA 01/2021
1	CationsIBA 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	CalciumIBA 01/2021
1	Thymidine Monophosphate (TMP)IBA 01/2021
1	iodopravadoline (AM 630)IBA 07/2020
1	Lipase (Acid Lipase)FDA Link 07/2020
1	AM 251 (AM251)IBA 07/2020
1	HU 308IBA 07/2020
1	EnzymesIBA 07/2020
1	Glycerol (Glycerine)FDA LinkGeneric 07/2020
1	JZL 184IBA 07/2020
1	CannabinoidsIBA 07/2020
1	CB2 Cannabinoid ReceptorIBA 07/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2020
1	ChloridesIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2019
1	Interferon-betaIBA 04/2019
1	InterferonsIBA 12/2018
1	LigandsIBA 12/2018
1	Toll-Like Receptor 2IBA 12/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2018
1	N- palmitoyl- S- (2,3- bis(palmitoyloxy)propyl)cysteinyl- seryl- lysyl- lysyl- lysyl- lysineIBA 10/2018
1	GW 6471IBA 10/2018
1	Therapeutic UsesIBA 10/2018
1	Lipid AIBA 01/2018
1	Saline SolutionIBA 01/2018
1	CytokinesIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Sulfamethoxazole FDA LinkGeneric 10/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 10/2017
1	ProteomeIBA 10/2017
1	Dopamine (Intropin)FDA LinkGeneric 10/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2017
1	sodium bisulfide (NaHS)IBA 09/2017
1	Diazepam (Valium)FDA LinkGeneric 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 10/2015
1	ConnexinsIBA 01/2013
1	Connexin 30IBA 12/2012
1	Gap Junction beta-1 ProteinIBA 12/2012
1	Aripiprazole (Abilify)FDA Link 10/2012
1	FlavonoidsIBA 05/2012

Therapy/Procedure

3	Therapeutics 09/2019 - 12/2012
2	Intraperitoneal Injections 07/2020 - 03/2016
2	Injections 01/2017 - 03/2016
2	Traditional Medicine (Folk Remedies) 01/2011 - 06/2004
1	Intravenous Infusions 01/2021
1	Polypharmacy 01/2021
1	Lasers (Laser) 01/2021
1	Aftercare (After-Treatment) 10/2017
1	Drug Therapy (Chemotherapy) 06/2013